J. Duitman (Lelystad, Netherlands), F. Franssen (Horn, Netherlands)
Persistent interstitial involvement in relation to the severity of SARS CoV-2 infection
A. Roca Noval (Madrid, Spain), R. García García (Madrid, Spain), M. Jiménez Gómez (Madrid, Spain), E. Catalinas Muñoz (Madrid, Spain), J. Diaz Miravalls (Madrid, Spain), L. Diab Cáceres (Madrid, Spain)
|   |
Modification of the Rheumatoid Arthritis (RA) Patient Reported Experience Measure (PREM) for patients with Interstitial Lung Disease (ILD)
J. Mandizha (Exeter, United Kingdom), A. Duckworth (Exeter, United Kingdom), H. Almond (Exeter, United Kingdom), G. Brown (Exeter, United Kingdom), S. Lines (Exeter, United Kingdom), A. Jorge Da Ponte (Exeter, United Kingdom), R. Shuttleworth (Exeter, United Kingdom), J. Lanario (Plymouth, United Kingdom), M. Steward (Exeter, United Kingdom), R. Sayers (Exeter, United Kingdom), C. Scotton (Exeter, United Kingdom), M. Gibbons (Exeter, United Kingdom), A. Russell (Exeter, United Kingdom)
| |
Late-onset noninfectious pulmonary complications after allogeneic hematopoietic stem cell transplantation- risk factors, prognosis
Ö. Isik (Ankara, Turkey), G. Cengiz Seval (Ankara, Turkey), S. Erol (Ankara, Turkey), S. Toprak (Ankara, Turkey), Ö. Özdemir Kumbasar (Ankara, Turkey)
| |
Immunoglobulin G4-related thoracic disease: clinical and radiological findings of an eastern mediterranean cohort
A. Alkan Öncel (Ankara, Turkey), G. Durhan (Ankara, Turkey), G. Yardimci (Ankara, Turkey), U. Ozden Sertcelik (Ankara, Turkey), B. Farisogullari (Ankara, Turkey), M. Ariyurek (Ankara, Turkey), O. Karadag (Ankara, Turkey), D. Koksal (Ankara, Turkey)
| |
COVID-19 patients : predictive factors for home therapy oxygen
N. Guediri (Tunis, Tunisia), I. Mejri Lajili (Tunis, Tunisia), N. Boubaker (Tunis, Tunisia), S. Dabboussi (Tunis, Tunisia), S. Mhamdi (Tunis, Tunisia), C. Aichaouia (Tunis, Tunisia), K. Ayed (Tunis, Tunisia), Z. Moatemri (Tunis, Tunisia)
| |
COVID-19 and comorbidity: possible complications of the complex pharmacotherapy
K. Gashynova (Dnipro, Ukraine), O. Kovalenko (Dnipro, Ukraine), O. Kovalenko (Dnipro, Ukraine), V. Rudakova (Dnipro, Ukraine)
| |
The examination of the second-line chemotherapy in SCLC patients with interstitial lung disease
R. Ozaki (Tokushima, Japan), H. Nokihara (Tokushima, Japan), Y. Yabuki (Tokushima, Japan), A. Mitsuhashi (Tokushima, Japan), H. Yoneda (Tokushima, Japan), K. Otsuka (Tokushima, Japan), H. Ogino (Tokushima, Japan), Y. Nishioka (Tokushima, Japan)
| |
Service evaluation of cardiac MRI imaging in patients presenting with an undiagnosed eosinophilia
H. Aung (Leicester, United Kingdom), K. Kyaw (Leicester, United Kingdom), M. Habib (Leicester, United Kingdom), S. Naveed (Leicester, United Kingdom), S. Siddiqui (London, United Kingdom)
| |
Distribution of sequelae in post-covid patients according to previous need of respiratory support
E. Buonamico (Bari, Italy), A. Portacci (Bari, Italy), F. Diaferia (Bari, Italy), P. Pierucci (Bari, Italy), E. Boniello (Bari, Italy), I. Iorillo (Bari, Italy), C. Locorotondo (Bari, Italy), S. Quaranta (Bari, Italy), E. Lulaj (Bari, Italy), G. Carpagnano (Bari, Italy)
| |
Long-term symptoms in patients with EVALI (e-cigarette or vaping associated lung injury) compared with people who vape
D. Blagev (Salt Lake City, United States), S. Callahan (Salt Lake City, United States), D. Harris (Salt Lake City, United States), D. Collingridge (Salt Lake City, United States), M. Hopkins (Salt Lake City, United States), J. Eve (Salt Lake City, United States), L. Waddoups (Salt Lake City, United States), V. Aston (Salt Lake City, United States), S. Brown (Salt Lake City, United States), M. Lanspa (Salt Lake City, United States)
| |
Bacterial Etiology of Slow Resolving Pneumonia in adults:Study of 138 cases
M. Irfan (Lahore, Pakistan), S. Amir Gilani (Lahore, Pakistan), E. Qureshi (Lahore, Pakistan), A. Rasheed Qureshi (Lahore, Pakistan)
| |
Predictive factors for Long COVID in adults previously hospitalized for COVID-19
I. Moussa (Ariana, Tunisia), T. Znegui (Ariana, Tunisia), I. Sahnoun (Ariana, Tunisia), M. Bougacha (Ariana, Tunisia), A. Allouche (Ariana, Tunisia), C. Ksouri (Ariana, Tunisia), L. Douik Elgharbi (Ariana, Tunisia)
| |
Gender differences in frequency-based parameters of COVID-19 cough at varying levels of disease severity
C. Davidson (Barcelona, Spain), O. Caguana (Barcelona, Spain), M. Lozano-García (Barcelona, Spain), M. Arita (Barcelona, Spain), L. Estrada-Petrocelli (Panama, Panama), I. Ferrer-Lluis (Barcelona, Spain), Y. Castillo-Escario (Barcelona, Spain), P. Ausín (Barcelona, Spain), J. Gea (Barcelona, Spain), R. Jané (Barcelona, Spain)
| |
Comparing patient outcomes from COVID-19 infection across three separate waves
P. Chohan (Dudley, United Kingdom), A. Crawford (Dudley, United Kingdom), M. Zafar (Dudley, United Kingdom), E. Wijayasinghe (Dudley, United Kingdom), M. Chaudri (Dudley, United Kingdom)
| |
Prone positioning procedure in COVID-19 radiological phenotypes
P. Tondo (Foggia, Italy), G. Scioscia (Foggia, Italy), F. Simone (Foggia, Italy), G. Giganti (Foggia, Italy), M. Salvemini (Foggia, Italy), A. Giuliani (Foggia, Italy), A. Hoxhallari (Foggia, Italy), M. Foschino Barbaro (Foggia, Italy), D. Lacedonia (Foggia, Italy)
| |
Younger Age as a Predictor of Mortality from COVID-19 in Hematological Patients
K. Gashynova (Dnipro, Ukraine), H. Usenko (Dnipro, Ukraine)
| |
Intra-hospital complications during SARS-CoV2 infection
s. marzouki (ariana, Tunisia), S. Louhaichi (ariana, Tunisia), B. Hamdi (ariana, Tunisia), J. Ammar (ariana, Tunisia), A. Hamzaoui (ariana, Tunisia)
| |
Interstitial lung abnormalities – real-world evidence
C. Rôlo Silvestre (Torres Vedras, Portugal), C. Custódio (Loures, Portugal), S. Clemente (Loures, Portugal), S. Rodrigues (Loures, Portugal), S. Furtado (Loures, Portugal), R. Maio (Loures, Portugal)
| |
Differencies between former smokers and non-smokers during post-Covid period
D. Ranilovic (Zagreb, Croatia), I. Marasovic (Zagreb, Croatia), I. Kovacevic (Zagreb, Croatia), Ð. Ljubicic (Zagreb, Croatia), J. Tekavec-Trkanjec (Zagreb, Croatia)
| |